Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection
Crossref DOI link: https://doi.org/10.1007/s40262-015-0240-z
Published Online: 2015-02-14
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Namour, Florence
Diderichsen, Paul Matthias
Cox, Eugène
Vayssière, Béatrice
Van der Aa, Annegret
Tasset, Chantal
Van‘t Klooster, Gerben
License valid from 2015-02-14